E-Tender For Procurement Of Some Drug Items Under Table-A, For Two Years From The Date Of Aoc. , Abiraterone Acetate Tab. 250 Mg , Aminophylline Inj 25Mg/Ml, 10 Ml. , Arsenic Trioxide Inj. 1Mg/Ml In 10 Ml Amp. , Aspirin Tab 75 Mg (Enteric Coated) , Busulfan Inj. (60Mg/10Ml)-Vial , Carvedilol 6.25Mg Tab. , Cefixime Syrup 50Mg/5Ml , Cefoperazone 0.5 G + Sulbactum 0.5 G Inj. , Cefuroxime Axetil Syrup 125Mg/5 Ml , Chloramphenicol-5% W/V + Betamethasone Valerate- 0.1% W/V + Lidocaine-2% W/V Ear Drop - 5Ml , Chlorthalidone Tab 12.5 Mg , Cholecalciferol 60000 Iu Tab/Cap , Cinacalcet 30 Mgtab. , Clonidine 0.1 Mg Tab. , Combined Gastric Antacid Chewable Tab. (Alum. + Mag. Hydroxide) (Total Salts Being Not Less Than 500) , Desmopressin Mouth Dissolving Tablets 60 Mcg , Dexmedetomidine Inj100 Mcg/Ml , Enalapril Maleate Tablet I.P. 2.5 Mg. , Entecavir1 Mg Tab , Etoricoxib 90Mg Tab. , Fluphenazine Inj. 25Mg , Fosaprepitant 150Mg Inj. , Framycetin Sulphate Oint. (1%) -30 Gm Tube , Gatifloxacin 0.3% W/V Eye Drop , Iron Sucrose In Iv 100Mg/Vial , Ketoconazole 200Mg Tab , Leflunomide 10 Mg Tab. , Lenalidomide Caps 10Mg , Lenvatinib 10Mg Caps. , Lenvatinib 4Mg Caps. , Levofloxacin 750 Mg Tab. , Lorazepam Inj. B.P. 2 Mg/ Ml -2 Ml Amp. , Mephentermine Inj. I.P. 15 Mg/ 1 Ml. Amp , Methotrexate Inj 500Mg , Mirabegron 50Mg Tab. , Naproxen 500Mg Tab. , Ofloxacin-0.3%W/V + Lignocaine-2% W/V Ear Drop , Paracetamol Drops Ip 100Mg/Ml (Phial Of 15 Ml ) With Dropper In A Mono Carton. , Pazopanib Tab 400Mg , Potassium Citrate 1100 Mg + Magnesium Citrate 375 Mg Syrup [Each 5 Ml Contains Potassium Citrate-1100 Mg + Magnesium Citrate-375 Mg ] , Quetiapine 50 Mg Tab , Ranitidine Syrup 75 Mg/5 Ml , Rifaximin 400 Mg Tab./Cap , Rifaximin 550 Mg Tab./Cap , Sertraline Tab. 25Mg , Sucralfate Oral Suspension 1G / 5Ml , Tamoxifen Citratetab. I.P. 20Mg. , Tenofovir 300Mg Tab , Theophylline 35Mg With Etophylline115 Mg Tab. (Cr) , Tolvaptan 15Mg Tab , Trypan Blue 6Mg Inj. (For Intraocular Use) , Vasopressin Inj. 20 Units/Ml , Zinc Acetate Syr 20Mg/5Ml , Important Note: 1. All Prospective Bidders Are Requested To Quote The Rate In Boq As Per Accounting Unit & Item Specification As Mentioned In The Table-A. Wrong Quoting Of The Rate In Boq Will Be Dealt With As Per Penal Provisions Of The T&C Of The Tender. 2. Quality Of The Product Supplied, May Be Ascertained By Testing / Physical Examination By The Experts At Any Stage Of The Tender Period. 3. The Prospective Bidders Of The Said Tender Are Requested To Make A Declaration In Affidavit Under Annexure Vi(B)In Case Of Sole Manufacturer/Importer (I.E. Proprietary In Nature). 4. If The Item(S) Under Sole Manufacturer / Importer Is (Are) Proprietary In Nature, Quarterly Intimation Is Solicited From The Approved Bidders Positively Regarding The Status Of Their Item(S) Proprietary In Nature, Otherwise Their Item(S) Will Be Blocked In The Smis. 5. In Case Of Tie Bid, Decision Will Be Taken By The Tia As Per G.O. No. 2320-F(Y), Dated 07.06.2022 Issued From Finance Department Audit Branch (Group T).
